Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  British Journal of Urology

• Publication date

  1995-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.1464-410X.1995.TB07347.XPMID 7537604
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stability of serum prostate-specific antigen determination across laboratory, assay, and storage time.

  1995cited by this paper
• Measurement of serum prostate specific antigen using IMx prostate specific antigen assay.

  1994cited by this paper
• Comparability of the Tandem-R and IMx assays for the measurement of serum prostate-specific antigen.

  1994cited by this paper
• Relationship between prostate specific antigen, prostate volume and age in the benign prostate.

  1993cited by this paper
• Prostate specific antigen levels in men older than 50 years without clinical evidence of prostatic carcinoma.

  1993cited by this paper
• The prevalence of prostatism: a population-based survey of urinary symptoms.

  1993cited by this paper
• Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.

  1993cited by this paper
• The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen.

  1992cited by this paper
• Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease.

  1992cited by this paper
• Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer.

  1992cited by this paper
• Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin.

  1991cited by this paper
• A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer.

  1991cited by this paper
• Determination of prostate volume by transrectal ultrasound.

  1991cited by this paper
• Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.

  1991cited by this paper
• Current status of prostate cancer in North American black males.

  1990cited by this paper
• Early diagnosis of prostate cancer.

  1987cited by this paper
• Early diagnosis of prostate cancer.

  1987cited by this paper
• The development of human benign prostatic hyperplasia with age.

  1984cited by this paper
• Latent carcinoma of prostate at autopsy in seven areas. Collaborative study organized by the International Agency for Research on Cancer, Lyons, France

  1977cited by this paper
• Comparative study of latent carcinoma of the prostate among Japanese in Japan and Hawaii.

  1973cited by this paper
• Health, normality, and the ghost of Gauss.

  1970cited by this paper

• Patterns of Presentation of Prostate Cancer in Patients of Non‐English‐Speaking Background at an Australian Institution—A 6‐Year Retrospective Study

  2025cites this paper
• Establishment of an age-specific reference range for serum total prostate-specific antigen levels among the Indian Bengali male population in a tertiary care hospital

  2025influential citation
• Investigation of importance Raman shifts in liquid biopsy diagnostics of prostate cancer

  2025cites this paper
• Maintenance avelumab in metastatic urothelial carcinoma: do tumour site and previous surgery matter?

  2025cites this paper
• Beyond the Number: Interpreting Prostate-Specific Antigen Elevation in the Context of Prostate Inflammation

  2025cites this paper
• Distribution of serum PSA in Chinese men: a preliminary community‐based study

  2025cites this paper
• Assessment of age specific serum Prostate Specific Antigen (PSA) levels for Indian population: A retrospective analysis at a tertiary healthcare facility

  2024cites this paper
• Need for age-specific prostate-specific antigen reference intervals in a Nigerian population

  2023cites this paper
• Determining age-specific prostate-specific antigen for healthy Indian men: A retrospective study

  2023cites this paper
• Ethnic differences in the age-related distribution of serum prostate-specific antigen values: A study in a Taiwanese male population

  2023influential citation
• Age-specific percentile-based prostate-specific antigen cutoff values predict the risk of prostate cancer: A single hospital observation

  2023cites this paper
• Relationship between serum prostate-specific antigen and transrectal prostate sonographic findings in asymptomatic Ugandan males

  2021cites this paper
• Age‐adjusted reference values for prostate‐specific antigen in a multi‐ethnic population

  2021cites this paper
• Age-Adjusted Reference Values for Prostate Specific Antigen - A Systematic Review and Meta-Analysis.

  2021cites this paper
• Nose size indicates maximum penile length

  2021cites this paper
• Prostate Specific Antigen and Prostate Volume; How They are Correlated in Patients with Benign Prostatic Hyperplasia

  2020cites this paper
• Asian Race and Risk of Prostate Cancer: Results from the REDUCE Study

  2020influential citation
• Learning what counting tells us

  2020cites this paper
• Relationship between serum prostate-specific antigen and age in cadavers

  2020cites this paper
• A novel screening strategy for clinically significant prostate cancer in elderly men over 75 years of age

  2020cites this paper
• Comparison of cancer detection rates by transrectal prostate biopsy for prostate cancer using two different nomograms based on patient’s age and prostate volume

  2019cites this paper
• Prevalence of post‐micturition dribble in Japanese men and its relationship with benign prostatic hyperplasia/lower urinary tract symptoms

  2019cites this paper
• Age-specific reference ranges of serum prostate-specific antigen in Iranian men

  2018cites this paper
• Age-Related Prostate Specific Antigen Reference Ranges in Healthy Northern Iranian Men.

  2018cites this paper
• Diagnosis in Prostate Cancer

  2018cites this paper
• Age-specific reference range of prostate-specific antigen in a population-based single-center study in the north of China

  2018cites this paper
• Influence of ethnicity on population reference values for biochemical markers

  2018cites this paper
• Detection of Prostate Specific Antigen (PSA) in Prostates patients

  2018cites this paper
• Influence of Ethnicity on Circulating Biochemical Markers in a Healthy Pediatric Cohort (CALIPER)

  2018cites this paper
• Diagnostic value of serum prostate-specific antigen in patients with potentially curable prostatic carcinoma

  2017cites this paper
• Post hoc analyses of East Asian patients from the randomized placebo-controlled PREVAIL trial of enzalutamide in patients with chemotherapy-naïve, metastatic castration-resistant prostate cancer

  2017cites this paper
• Does Race/Ethnicity Have a Role in a Link Between Lower Urinary Tract Symptoms and Metabolic Syndrome?

  2017cites this paper
• Serum PSA levels in the Indian population: Is it different?

  2017cites this paper
• Race / ethnicity and criminal behavior : Neurohormonal in fl uences

  2017cites this paper
• Prostate cancer detection rate in Indonesian men.

  2017cites this paper
• Race/ethnicity and criminal behavior: Neurohormonal influences

  2017cites this paper
• Age-specific Serum Prostate Specific Antigen Ranges Among Apparently Healthy Nigerian Men Without Clinical Evidence of Prostate Cancer

  2016cites this paper
• The PREVAIL trial of enzalutamide in men with chemotherapy-naïve, metastatic castration-resistant prostate cancer: Post hoc analysis of Korean patients

  2016cites this paper
• Predictors of Positive Bone Metastasis in Newly Diagnosed Prostate Cancer Patients.

  2016cites this paper
• Prostate‐specific antigen lowering effect of metabolic syndrome is influenced by prostate volume

  2016cites this paper
• Clarifying the PSA grey zone: The management of patients with a borderline PSA

  2016cites this paper
• Enzalutamide in Japanese patients with chemotherapy‐naïve, metastatic castration‐resistant prostate cancer: A post‐hoc analysis of the placebo‐controlled PREVAIL trial

  2016cites this paper
• Chapter 53 – Prostate Cancer

  2016cites this paper
• Development of novel biosensing and diagnostic platforms using nanoparticle complexes

  2015cites this paper
• The optimal number of initial prostate biopsy cores in daily practice: a prospective study using the Nara Urological Research and Treatment Group nomogram

  2015cites this paper
• Vapoenucleation of the prostate using a high-power thulium laser: a one-year follow-up study

  2015cites this paper
• Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0–10.0 ng/ml

  2015cites this paper
• The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men

  2015cites this paper
• Percent free prostate-specific antigen for prostate cancer diagnosis in Chinese men with a PSA of 4.0–10.0 ng/mL: Results from the Chinese Prostate Cancer Consortium

  2015cites this paper
• Establishment of Age Specific Reference Range of Serum PSA Level among Healthy Indian Hindu and Muslim Males

  2014cites this paper
• WITHDRAWN: Prostate cancer in Asia: A collaborative report

  2014cites this paper
• A hospital based study on reference range of serum prostate specific antigen levels

  2014cites this paper
• CÁNCER DE PRÓSTATA LOCALIZADO TRATADO CON CIRUGÍA RADICAL. EXPERIENCIA DE UN CENTRO.

  2014cites this paper
• Ethnicity Is an Independent Determinant of Age-Specific PSA Level: Findings from a Multiethnic Asian Setting

  2014influential citation
• THE RELATIONSHIP BETWEEN CALCIUM AND PROSTATE SPECIFIC ANTIGEN LEVELS IN PATIENTS WITH PROSTATE HYPERPLASIA AND PROSTATE CANCER

  2014cites this paper
• Prostate cancer in Asia: A collaborative report

  2014cites this paper
• Nano-Based PSA Biosensors: An Early Detection Technique of Prostate Cancer

  2014cites this paper
• Prostate cancer in Asian men

  2014cites this paper
• Vergleich des Differenzierungsgrades (Gleason-Score) beim Prostatakarzinom zwischen präoperativer Biopsie und Prostatektomiepräparat

  2014cites this paper
• Reference Ranges of Age-Related Prostate-Specific Antigen in Men without Cancer from Beijing Area

  2013cites this paper
• Incidence and risk of treatment for benign prostatic hyperplasia in Japanese men: A 15‐year longitudinal community‐based study

  2013cites this paper
• Diagnostic dilemma in histopathology report following robot assisted laparoscopic prostatectomy: tumour 'hide and seek'.

  2013cites this paper
• Natural History of Lower Urinary Tract Symptoms Secondary to BPH

  2013cites this paper
• [Prostate adenocarcinoma. Predictive clinical model of seminal vesicle involvement].

  2013cites this paper
• Examining the value PSA=10ng/ml as a cutoff for predicting metastatic bone disease in NaF18 PET/CT bone scans: a pilot study

  2012cites this paper
• Age-specific reference ranges for prostate-specific antigen among healthy Syrian men

  2012influential citation
• Can the prostate risk calculator based on western population be applied to asian population?

  2012cites this paper
• Prostate‐specific antigen levels in men aged 70 years and over: findings from the CHAMP study

  2012cites this paper
• Prostate Volume Measurement by Transrectal Ultrasonography in the Healthy Korean Men in Thirties

  2012cites this paper
• Natural history of lower urinary tract symptoms in Japanese men from a 15‐year longitudinal community‐based study

  2012cites this paper
• Practice Patterns of Korean Urologists for Screening and Managing Prostate Cancer according to PSA Level

  2012cites this paper
• Performance of prostate‐specific antigen mass in estimation of prostate volume in Japanese men with benign prostate hyperplasia

  2012cites this paper
• The Distribution of PSA Age-Specific Profiles in Healthy Irish Men between 20 and 70

  2012cites this paper
• Efficacy and safety of dutasteride on prostate cancer risk reduction in Asian men: the results from the REDUCE study.

  2011cites this paper
• Clinical and pathological characteristics of screen-detected versus clinically diagnosed prostate cancer in Nanjing, China

  2011cites this paper
• Distribution of serum prostate-specific antigen in Chinese healthy men: a population-based study.

  2011cites this paper
• Internal prostatic architecture on transrectal ultrasonography predicts future prostatic growth: Natural history of prostatic hyperplasia in a 15‐year longitudinal community‐based study

  2011cites this paper
• Age-specific reference ranges of serum prostate-specific antigen in Iraqi men

  2011cites this paper
• Distribution of PSA velocity by total PSA levels: data from the Baltimore Longitudinal Study of Aging.

  2011cites this paper
• Is it suitable to eliminate bone scan for prostate cancer patients with PSA ≤ 20 ng/mL?

  2011cites this paper
• Electrophoretic fingerprint metallothionein analysis as a potential prostate cancer biomarker

  2011cites this paper
• Age-related reference levels of serum prostate-specific antigen among Taiwanese men without clinical evidence of prostate cancer.

  2010influential citation
• Prostate Cancer: Recent Trends in Korea

  2010cites this paper
• Outcome of Prostate Biopsy in Men Younger than 40 Years of Age with High Prostate-Specific Antigen (PSA) Levels

  2010cites this paper
• Prostate cancer screening and determining the appropriate prostate-specific antigen cutoff values.

  2010cites this paper
• Preoperative Clinical and Pathological Characteristics of pT0 Prostate Cancer in Radical Prostatectomy

  2010cites this paper
• The value of prostate-specific antigen in Asia

  2010cites this paper
• Clinical Implications of Residual Urine in Korean Benign Prostatic Hyperplasia (BPH) Patients: A Prognostic Factor for BPH-Related Clinical Events

  2010cites this paper
• Association of Polymorphisms in the Prostate-Specific Antigen (PSA) Gene Promoter with Serum PSA Level and PSA Changes after Dutasteride Treatment in Korean Men with Benign Prostatic Hypertrophy

  2010cites this paper
• What Are Some New Developments in Prostate Cancer Diagnosis

  2010cites this paper
• Age specific reference levels of serum prostate-specific antigen, prostate volume and prostate specific antigen density in healthy Iranian men.

  2009cites this paper
• Subfractions and Derivatives of Total Prostate-Specific Antigen in the Early Detection of Prostate Cancer

  2009cites this paper
• What is the most appropriate test in detecting prostate cancer in patients with intermediate prostate specific antigen levels

  2009cites this paper
• Efficacy and safety of dutasteride, tamsulosin and their combination in a subpopulation of the CombAT study: 2-year results in Asian men with moderate-to-severe BPH

  2009cites this paper
• Prostate kallikrein markers in diagnosis, risk stratification and prognosis

  2009cites this paper
• A population based epidemiological study on benign prostatic obstruction in a suburban district of Istanbul Selim prostatik obstrüksiyon üzerine İstanbul'un bir banliyösünde gerçekleştirilen toplum temelli epidemiyolojik bir çalişma

  2009cites this paper
• Changes in prostate volume in Japanese patients with benign prostatic hyperplasia: Association with other urological measures and risk of surgical intervention

  2009cites this paper
• Changes in prostate-specific antigen levels and prostate volume in octogenarian men: community-based study.

  2009cites this paper
• A Population Based Epidemiological Study on Benign Prostatic Obstruction in a Suburban District of Istanbul

  2009cites this paper
• The Association of Metabolic Syndrome and Prostate-Specific Antigen

  2009cites this paper